Drugs in Context is a peer-reviewed english-language open-access journal published by BioExcel Publishing Ltd in United Kingdom, operating under an open-access model since 2005. The journal covers Therapeutics. Pharmacology.
Authors are required to pay an article processing charge to publish in Drugs in Context; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY-NC-ND license (see other journals using this license).
To date, Drugs in Context has published 571 articles. Articles are minted with DOIs through the prefix 10.7573. All submissions undergo plagiarism screening before peer review.
Keywords
pharmacotherapy, real-world medicine, disease management, drugs, health economics, health outcomes
At a glance
- Publisher
- BioExcel Publishing Ltd
- Country
- United Kingdom
- Primary language
- English
- License
- CC BY-NC-ND
- Peer review
- Anonymous peer review
- OA since
- 2005
- Review time
- 9 weeks
- DOI prefix
10.7573- Plagiarism check
- Yes
ISSN
- electronic
- 1740-4398
Frequently asked questions
Is Drugs in Context peer-reviewed?
Does Drugs in Context charge an article processing charge (APC)?
What subjects does Drugs in Context publish?
What languages does Drugs in Context accept?
What is the ISSN of Drugs in Context?
1740-4398 (electronic).